Warburg Pincus Near $7 Billion Acquisition of PANTHERx Rare
Private equity firm Warburg Pincus is close to acquiring specialty pharmacy company PANTHERx Rare for over $7 billion, including debt. The deal would be backed by Abu Dhabi Investment Authority and marks a significant move in the healthcare sector amid increased private equity activity.
Topics: Healthcare Pharmaceuticals Private Equity